Compound: FDB023465 (Lactosylceramide (d18:1/12:0))
Term: Hypobetalipoproteinemia
Definition: A hypolipoproteinemia characterized by permanently low levels of apolipoprotein b and ldl cholesterol resulting from an impaired ability to absorb and transport fats. (do).
Parent Term: Health condition
Parent Definition: A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.
Other Compounds Mapped to 'Hypobetalipoproteinemia'